Lyons, France

Claire Corot

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Claire Corot: Innovator in Pharmaceutical Formulations

Introduction

Claire Corot is a prominent inventor based in Lyons, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of contrast agents. With a total of seven patents to her name, Claire has established herself as a leading figure in her area of expertise.

Latest Patents

One of Claire Corot's latest patents involves a process for preparing a liquid pharmaceutical formulation containing a complex of macrocyclic chelate with a lanthanide. This innovative process specifies a mol/mol amount of free macrocyclic chelate ranging from 0.002% to 0.4%, with optimal concentrations between 0.025% and 0.25%. The macrocyclic chelate is preferably DOTA, and the process includes several steps, such as the preparation of the liquid composition, measurement of concentrations, and adjustments to achieve the target concentration of free macrocyclic chelate in the final formulation.

Career Highlights

Claire Corot is currently employed at Guerbet, a company known for its advancements in medical imaging and contrast agents. Her work at Guerbet has allowed her to focus on innovative solutions that enhance the efficacy of pharmaceutical formulations.

Collaborations

Some of Claire's notable coworkers include Marc Port and Dominique Meyer. Their collaboration has contributed to the success of various projects within the company.

Conclusion

Claire Corot's work in the field of pharmaceutical formulations has led to significant advancements in the preparation of contrast agents. Her innovative processes and dedication to research continue to impact the medical imaging industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…